Caitlin Raymond on Platelet Refractoriness: New Series Alert!
Caitlin Raymond, a board-certified Clinical Pathologist and current Transfusion Medicine Fellow at the National Institutes of Health, shared on LinkedIn:
“New Blog Post: Platelet Refractoriness — An Overview
One of the most frustrating challenges in transfusion medicine is when platelet transfusions don’t “stick.”
Platelet refractoriness is common, multifactorial, and has huge implications for bleeding risk, patient outcomes, and stewardship of scarce blood products.
In this post, I walk through:
- How we define and measure refractoriness (CCI)
- Why non-immune causes (like sepsis, bleeding, or splenomegaly) are the most common and should be ruled out first
- How we evaluate immune causes with HLA typing, antibody screens, PRA, and crossmatches
- Practical management strategies, from HLA-compatible platelets to PRA-guided selection
- The real-world challenges of balancing ideal care with limited resources
Key takeaway: Refractoriness isn’t rare—and a structured approach can make transfusion both safer for patients and more sustainable for the blood supply.”
Read the full post here.
More from Caitlin Raymond featured in HT!
More series on coagulation featured in Hemostasis Today.
-
Aug 25, 2025, 09:26Caitlin Raymond on Platelet Refractoriness: New Series Alert!
-
Aug 23, 2025, 16:06Hemophilia Doesn’t Define Me—Skyler Tulley’s 100-Mile Challenge
-
Aug 23, 2025, 08:34Mamas A. Mamas Highlights UK Registry Data on STEMI Mortality and Infarct Size Trends
-
Aug 23, 2025, 08:28Len Valentino Named Researcher of the Year at BDC 2025
-
Aug 23, 2025, 08:26Thomas Reiser Highlights ISTH Pulse Podcast: Geoffrey Barnes Interviews Fionnuala Ní Áinle on Guideline Development
-
Aug 25, 2025, 10:40Maria Filomena Ruberto on The Hypercoagulable State
-
Aug 25, 2025, 08:28The Galeno Study: Doris Barcellona’s Insights on Oral Anticoagulants-related Bleeding
-
Aug 25, 2025, 08:16Wolfgang Miesbach on AAV5 Antibodies in Hemophilia B Gene Therapy
-
Aug 23, 2025, 16:30Benjamin Terrier: RCT Shows Rituximab Outperforms Conventional Therapy for Remission Induction in EGPA Annals of Int Med
-
Aug 23, 2025, 08:33British Journal of Haematology – Ferritin and Haemoglobin Recovery Patterns
-
Aug 18, 2025, 23:56Dr. Arun V. J Invites You to His Lecture on ‘AI and Data Sciences in Transfusion Medicine’ at the AI in Healthcare Conclave. Register now!
-
Aug 18, 2025, 23:50Safe and Efficient Thrombectomy with Artix System: Clinical Insights from Neil Desai and Colleagues
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Aug 23, 2025, 07:48Protecting Heart and Brain Health: Stroke Prevention in Women with Bleeding Disorders: NBDF
-
Aug 21, 2025, 15:08Global Variations in Blood Collection: What Explains the Differences?
-
Aug 20, 2025, 13:33Askat's Life with Hemophilia A after Access to Prophylactic Treatment Through the WFH Humanitarian Aid Program
-
Aug 19, 2025, 17:22Louise Bannon Encourages You to Support World Thrombosis Day!
-
Aug 17, 2025, 07:31Melissa Korn's story: Recognizing Pulmonary Embolism Symptoms Can Save Lives, NBCA